Level Bio
0.27 SEK
0.00 %
Less than 1K followers
LEVBIO
NGM Growth Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
0.00 %
-7.48 %
-15.00 %
-9.33 %
-20.00 %
-30.61 %
-58.79 %
-81.99 %
-97.27 %
Level Bio is active in medical technology that develops, manufactures and distributes innovative diagnostics. The company's products are sold under several brands and through its own distributors, mainly to laboratories and research institutes. The company's largest operations are found in the Nordic market. Level Bio is headquartered in Stockholm.
Read moreMarket cap
18.6M SEK
Turnover
4.46K SEK
Revenue
32.36M
EBIT %
-10.78 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20/5
2026
General meeting '26
20/8
2026
Interim report Q2'26
22/10
2026
Interim report Q3'26
All
Press releases
3rd party
ShowingAll content types
Quanor: Level Bio ökar omsättningen med 15 procent i Q1 och slutför avyttring av CyberGene
Delårsrapport för första kvartalet 2026 Level Bio AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools